Understanding how a specific brain condition leads to early-onset dementia
Elucidating the mechanisms by which microgliopathy causes early-onset dementia
This study is looking into how Nasu-Hakola Disease, a rare genetic condition that causes early dementia, affects the brain, with the hope of finding new ways to help people with this and similar conditions.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11057341 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind Nasu-Hakola Disease (NHD), a rare genetic condition that causes early-onset dementia. By examining brain tissue from affected individuals, the study aims to understand how mutations in specific genes lead to abnormal microglial responses, which may contribute to rapid disease progression. The researchers will utilize advanced techniques like single nucleus RNA sequencing to analyze the unique signaling pathways involved in this condition. The ultimate goal is to identify potential therapeutic targets that could improve outcomes for patients with similar dementias.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Nasu-Hakola Disease or those with early-onset dementia linked to genetic factors.
Not a fit: Patients with common forms of Alzheimer's disease without genetic mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for early-onset dementia and improve the quality of life for affected individuals.
How similar studies have performed: While research on Nasu-Hakola Disease is limited, understanding genetic dementias has shown promise in identifying new therapeutic approaches in related conditions.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Colonna, Marco — Washington University
- Study coordinator: Colonna, Marco
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.